Latest Updates of Key Players in the Exoskeleton Market and Growth Factors 2026-2035
Get a personalized Exoskeleton Market sample highlighting segments, growth stats, and competitor moves: Download Now
| Company | Headquarters | Latest Update |
| Ekso Bionics | United States | Ekso Bionics is a foremost developer of exoskeleton services that amplify human potential by supporting or improving strength, endurance, and mobility across healthcare and industrial applications. |
| ARMASTEC PTE. LTD | Singapore | ArmasTec develops ground-breaking fabric-based exoskeletons intended to significantly lower physical strain and enhance workplace safety. |
| Hocoma | United States | Hocoma's robotic products are exoskeletons as they are attached to one or more human joints but are fixed to a platform. |
| Lockheed Martin Corporation | United States | Lockheed Martin continues to be recognized as a leading player in the military exoskeleton. |
| Suit X | United States | suitX focuses on passive exoskeletons for workers and a gait rehabilitation powered healthcare exoskeleton. |
| Rex Bionics Plc. | United Kingdom | Rex Bionics progresses and commercializes robotic, self-supporting exoskeletons intended for rehabilitation and patients' mobility. |
Supply Chain Analysis
R&D:
- The Research and Development (R&D) processes for medical care exoskeletons include highly multidisciplinary strategies, integration of material science, robotics, biomechanics, and AI to create wearable tools that assist with rehabilitation or mobility.
- Key Players: Abbott Laboratories and Canon
Manufacturing Processes:
- The manufacturing of healthcare exoskeletons includes a multidisciplinary strategy, blending advanced materials science, biomechanical engineering, and robotics. The process ensures these wearable devices are durable, lightweight, and safe for human interaction.
- Key Players: Philips Healthcare and Natus Medical
Patient Services:
- Patient services, including healthcare exoskeletons, are significantly focused on rehabilitation, mobility assistance, and growing independence for patients with severe motor impairments caused by conditions such as spinal cord injuries (SCI), strokes, and neurodegenerative diseases.
- Key Players: Siemens Healthineers and GE Healthcare
Market Forecast
The global exoskeleton market size was estimated at USD 595.12 million in 2025 and is predicted to increase from USD 681.53 million in 2026 to approximately USD 2308.97 million by 2035, expanding at a CAGR of 14.52% from 2026 to 2035.
Recent Developments in the Exoskeleton Market
- In February 2026, Lifeward Ltd. announced it has entered into a definitive agreement to acquire some technology assets and related know-how, including functional prototypes from Skelable Ltd., the creator of a robotic upper body orthotic tools with AI-based capabilities, for entire consideration of $480,000 in Lifeward equity, payable in installments upon the attainment of specified milestones, and a nominal cash payment at closing.
- In May 2025, BTL, a Czech healthcare technology producer, acquired the Italian start-up U&O, which specializes in the advancement and manufacturing of exoskeletons. U&O presently produces around 50 exoskeletons yearly for patients with spinal cord damage.
Keypoints
- Company Overview
- Locations Subsidiaries/Geographic reach
- Key Executives
- Company Financials
- Patents registered
- SWOT Analysis
- Applications Catered
- Strategic collaborations
- Recent Developments
- Competitive Benchmarking
